Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults

European Journal of Epidemiology

Volumn 19, Issue 1, 2004, Pages 41-47

  Johnsen, Søren Paaske ^a,b   Sorensen H T ^a   Thomsen, J L ^c   Gronbaek H ^d   Flyvbjerg, A ^d   Engberg, M ^c   Lauritzen, T ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b Dept of Epidemiol and Social Med ^*  (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidemiology; Fetal growth; Insulin like growth factor binding protein 3; Insulin like growth factor I; Insulin like growth factor II

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ADULTHOOD; ANALYTICAL PARAMETERS; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; BODY HEIGHT; CANCER RISK; CARDIOVASCULAR RISK; DENMARK; FEMALE; FETUS GROWTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; SEX DIFFERENCE; STATISTICAL MODEL; WEIGHT INDEX;

AGED; BIOLOGICAL MARKERS; BIRTH WEIGHT; BODY HEIGHT; CARDIOVASCULAR DISEASES; DENMARK; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; NEOPLASMS;

EID: 1342323934     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000013396.40006.8f     Document Type: Article

References (29)

1. Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prev Soc Med 1977; 31: 91-95.
2. Joseph KS, Kramer MS. Review of the evidence on fetal and early childhood antecedents of adult chronic disease. Epidemiol Rev 1996; 18: 158-174.
3. Barker DJP. Fetal origins of coronary heart disease. Br Med J 1995; 311: 171-174.
4. Fall CH, Osmond C, Barker DJP, et al. Fetal and infant growth and cardiovascular risk factors in women. Br Med J 1995; 310: 428-432.
5. Ekbom A, Hsieh CC, Lipworth L, et al. Perinatal characteristics in relation to incidence and mortality from prostate cancer. Br Med J 1996; 313: 337-341.
6. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine environment and breast cancer risk in women: A population-based study. J Natl Cancer Inst 1997; 89: 71-76.
7. Andersson SW, Bengtsson C, Hallberg L, et al. Cancer risk in Swedish women: The relation to size at birth. Br J Cancer 2001; 84: 1193-1198.
8. Ekbom A. Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 1998; 8: 237-244.
9. Gluckman PD. The endocrine regulation of fetal growth in late gestation: The role of insulin-like growth factors. J Clin Endocrinol Metab 1995; 80: 1047-1050.
10. Gluckman PD, Pinal CS. Maternal-placental-fetal interactions in the endocrine regulation of fetal growth. Endocrine 2002; 19: 81-89.
11. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998; 279: 563-566.
12. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-1396.
13. Ruotolo G, Båvenholm P, Brismar K, et al. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: Beneficial effects of bezafibrate treatment. J Am Coll Cardiol 2000; 35: 647-654.
14. Frystyk J, Ledet T, Møller N, Flyvbjerg A, OØrskov H. Cardiovascular disease and insulin-like growth factor I. Circulation 2002; 106: 893-895.
15. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease, Circulation 2002; 106: 939-944.
16. Fall CHD, Pandit AN, Law CM, et al. Size at birth and plasma insulin-like growth factor-I concentrations. Arch Dis Child 1995; 73: 287-293.
17. Garnett S, Cowell CT, Bradford D, et al. Effects of gender, body composition and birth size on IGF-I in 7- and 8-year old children. Horm Res 1999; 52: 221-229.
18. Jernström H, Olsson H. Insulin-like growth factor-I in relation to adult weight and birth weight in healthy nulliparous women. Int J Gynaecol Obstet 1998; 62: 11-18.
19. Lauritzen T, Lebouef-Yde C, Lunde IM, Nielsen KDB. Ebeltoft project: Baseline data from a five year randomized, controlled, prospective health promotion study in a Danish population. Br J Gen Prac 1995; 45: 542-547.
20. Frystyk J, Dinesen B, OØrskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and 11. Growth Regul 1995; 5: 169-176.
21. Greenland S. Modeling and variables selection in epidemiologic analysis. Am J Public Health 1989; 79: 340-349.
22. Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995; 80: 2534-2542.
23. Frystyk J, Skjaerbaek C, Dinesen B, OØrskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 1994; 384: 185-191.
24. Collett-Solberg PF, Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000; 12: 121-136.
25. D'Ercole AJ, Ye P, Gutierrez-Ospina G. Use of transgenic mice for understanding the physiology of insulin-like growth factors. Horm Res 1996; 45(Suppl 1): 5-7.
26. Yang SW, Yu JS. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight. Pediatr Int 2000; 42: 31-36.
27. Woods KA, Camacho-Hübner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363-1367.
28. Vaessen N, Janssen JA, Heutink P, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002; 359: 1036-1037.
29. Gluckman PD, Harding JE. Fetal growth retardation: Underlying endocrine mechanisms and postnatal consequences. Acta Paediatr Suppl 1997; 422: 69-72.